Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medacta Group SA
  6. News
  7. Summary
    MOVE   CH0468525222

MEDACTA GROUP SA

(MOVE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Medacta : announces the publication of 2020 Sustainability Report

07/21/2021 | 04:15am EDT
'In 2020, despite the challenging conditions caused by the COVID-19 pandemic, we remained committed to our path of a sustainable growth, aimed at creating value for all our Stakeholders.
We continued to develop new products and solutions with the aim of improving patient wellbeing and facilitating the work of medical professionals, healthcare administration and logistics staff. In 2020 over 30 new products across our business lines were cleared. Among them I would like to mention NextARTM, our Augmented Reality-Based Surgical Platform with its first application for Total Knee Replacement. This surgical platform perfectly fits with our strategy to allow potential benefits for both Patients and the Healthcare systems thanks to NextAR surgical accuracy and limited upfront capital investment and reduced cost per case compared with other technologies.
During the year, we significantly expanded our online educational activities through the launch of the M.O.R.E. in Touch program, a series of webcasts and web-based events discussing current topics in orthopedics. This program allowed to connect expert physicians from all over the world, making top-level medical education available everywhere and at any time.
We continued to maintain a constant dialogue with our employees, who continued to show a high level of commitment and dedication to manage the crises generated by the pandemic
and to execute our strategy. We firmly believe that Medacta's culture is a key for sustainable success, actively contributing to our growth. Therefore, our #beMedcata campaign was expanded worldwide and subsequently we updated our Group Performance Review system according to our values. A long-term incentive plan for our Group Executive Management and selected key managers and employees will enhance and reward loyalty of our people. The plan will provide the eligible employees with an opportunity to become shareholders of the
Company and hence align their interest to those of our existing Shareholders. Furthermore, we intend to adopt a succession plan for our key people and key positions worldwide in 2021.
Our initiatives to protect the environment include a reduction of CO2 emissions, a continued replacement of traditional lights by LED lights, a further improvement of efficiency in the heating systems of our production facilities and the complete elimination of fuel oil at the end of the year. Our initiatives aimed at protecting the environment include the utilization of 100% green energy in our manufacturing plants since 2021.
Furthermore, our Foundation supported many charitable and social projects, including initiatives aimed at protecting the rights of children and young people and helping people in a distressful situation. In 2021 we will continue our engagement on the social community through our Foundation, including our support to humanitarian initiatives worldwide, as soon as the pandemic conditions will allow for it.'
Francesco Siccardi, CEO of Medacta
For more information, please visit: sustainability.medacta.com

Disclaimer

Medacta Group SA published this content on 21 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 July 2021 08:14:05 UTC.


© Publicnow 2021
All news about MEDACTA GROUP SA
09/16MEDACTA : celebrates the milestone of 10,000 Medacta Shoulder System implanted w..
PU
09/14MEDACTA : Credit Suisse Lifts Price Target on Medacta Group, Maintains Neutral R..
MT
09/10MEDACTA : Swiss Medical Device Maker Medacta's H1 Profit Climbs as All Business ..
MT
09/10MEDACTA : reports strong profitability with 31.9% adjusted EBITDA margin in the ..
PU
09/10MEDACTA : Press Release – 2021 Half-Year Results
PU
09/10MEDACTA : 2021 Half-Year Report
PU
09/10MEDACTA : 2021 Half-Year Presentation
PU
09/10Medacta reports strong profitability -2-
DJ
09/10Medacta reports strong profitability with 31.9% adjusted EBITDA margin in the..
DJ
09/10Medacta Group SA Confirms Revenue Guidance for the Year 2021
CI
More news
Analyst Recommendations on MEDACTA GROUP SA
More recommendations
Financials
Sales 2021 348 M 408 M 408 M
Net income 2021 56,0 M 65,7 M 65,7 M
Net Debt 2021 83,5 M 97,9 M 97,9 M
P/E ratio 2021 49,7x
Yield 2021 0,54%
Capitalization 2 783 M 3 270 M 3 263 M
EV / Sales 2021 8,24x
EV / Sales 2022 7,15x
Nbr of Employees 1 246
Free-Float 30,5%
Chart MEDACTA GROUP SA
Duration : Period :
Medacta Group SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDACTA GROUP SA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 139,16 €
Average target price 107,02 €
Spread / Average Target -23,1%
EPS Revisions
Managers and Directors
Francesco Siccardi Chief Executive Officer
Corrado Farsetta Chief Financial Officer
Alberto Siccardi Executive Chairman
Victor Waldemar Balli Lead Independent Non-Executive Director
Philippe A. Weber Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDACTA GROUP SA73.74%3 270
ABBOTT LABORATORIES15.80%224 776
MEDTRONIC PLC10.72%174 552
BECTON, DICKINSON AND COMPANY4.69%75 229
HOYA CORPORATION30.10%62 323
ALIGN TECHNOLOGY, INC.34.62%56 839